---
figid: PMC4904747__AJTS-10-1-g016
figlink: /pmc/articles/PMC4904747/figure/F16/
number: F16
caption: JAK STAT pathway. Ruxolitinib acts on this pathway for treating myeloproliferative
  neoplasms especially primary myelofibrosis
pmcid: PMC4904747
papertitle: Is cancer chemotherapy dying?.
reftext: M. B. Agarwal. Asian J Transfus Sci. 2016 May;10(Suppl 1):S1-S7.
pmc_ranked_result_index: '80545'
pathway_score: 0.933885
filename: AJTS-10-1-g016.jpg
figtitle: JAK STAT pathway
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4904747__AJTS-10-1-g016.html
  '@type': Dataset
  description: JAK STAT pathway. Ruxolitinib acts on this pathway for treating myeloproliferative
    neoplasms especially primary myelofibrosis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK1
  - JAK2
  - STAT1
genes:
- word: (Jak1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: Jak2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
chemicals: []
diseases: []
figid_alias: PMC4904747__F16
redirect_from: /figures/PMC4904747__F16
figtype: Figure
---
